Draft guidance consultation You can now review and comment on this draft guideline. The consultation closes on Tuesday 08 July 2025 at 5pm. In line with NICE’s commitment to incorporate technology ...

Browse the complete list of all our published health and social care guidance, including guidelines, NICE advice and quality standards ...

NICE news for life sciences Every 2 months Our latest news and updates for those working within the life sciences sector. Subscribe for information on: our work to improve patient access to innovative ...

Home NICE Guidance Conditions and diseases Musculoskeletal conditions Arthritis Sarilumab for treating polyarticular or oligoarticular juvenile idiopathic arthritis in people 2 to 17 years [ID6297] ...

Home NICE Guidance Conditions and diseases Diabetes and other endocrinal, nutritional and metabolic conditions Obesity Setmelanotide for treating acquired hypothalamic obesity in people 4 years and ...

In this guest blog, Dale Greenwood, mental health lead for East London NHS Foundation Trust, shares how his trust implemented a digital innovation to support children's mental health. In recent years, ...

Marstacimab (Hympavzi, Pfizer) is indicated for 'routine prophylaxis of bleeding episodes in patients 12 years of age and older, weighing at least 35 kg, with: severe haemophilia A (congenital factor ...

Evidence-based recommendations on transcatheter aortic valve implantation (TAVI) for native aortic valve regurgitation. This involves implanting a replacement valve inside the faulty native valve.

Marstacimab for treating severe haemophilia A or B in people 12 years and over without anti-factor antibodies Technology appraisal guidance TA1073 Published: 24 June 2025 ...

New generation cardiac CT scanners (Aquilion ONE, Brilliance iCT, Discovery CT750 HD and Somatom Definition Flash) for cardiac imaging in people with suspected or known coronary artery disease in whom ...

Burosumab for treating X-linked hypophosphataemia in children and young people HST8 10 October 2018 8 April 2025 Olipudase alfa for treating acid sphingomyelinase deficiency (Niemann–Pick disease) ...

A bioprosthetic aortic valve is implanted within the damaged native aortic valve. Access to the aortic valve can be percutaneous, with entry to the circulation through the femoral artery (endovascular ...